InvestorsHub Logo
Followers 52
Posts 9089
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Wednesday, 07/05/2023 8:03:45 AM

Wednesday, July 05, 2023 8:03:45 AM

Post# of 13461
Moderna agrees deal in China with view to developing mRNA medicines

https://finance.yahoo.com/news/1-moderna-agrees-deal-china-095651433.htm

Moderna has submitted marketing authorization applications for the investigational RSV vaccine, mRNA-1345, with the European Medicines Agency, Swissmedic, and the Therapeutic Goods Administration in Australia

The Company has also initiated a rolling submission of a Biologics License Application to the U.S. Food and Drug Administration for mRNA-1345

mRNA-1345 met primary efficacy endpoints, demonstrating vaccine efficacy of 83.7% against RSV lower respiratory tract disease in older adults in the Phase 3 pivotal efficacy trial, ConquerRSV

The Company plans further regulatory submissions for mRNA-1345 worldwide

https://investors.modernatx.com/news/news-details/2023/Moderna-Announces-Global-Regulatory-Submissions-For-Its-Respiratory-Syncytial-Virus-RSV-Vaccine-MRNA-1345/default.aspx
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News